tiprankstipranks
Trending News
More News >
Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
US Market

Avenue Therapeutics (ATXI) Financial Statements

Compare
331 Followers

Avenue Therapeutics Financial Overview

Avenue Therapeutics's market cap is currently $2.39M. The company's EPS TTM is $; its P/E ratio is -0.51; Avenue Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -11.28M$ -14.54M$ -8.04M$ -3.74M$ -5.21M
EBITDA$ -11.70M$ 4.05M$ -2.44M$ 7.00K$ -5.15M
Net Income$ -11.65M$ -10.38M$ -3.55M$ -3.73M$ -5.15M
Balance Sheet
Cash & Short-Term Investments$ 2.59M$ 1.78M$ 6.71M$ 3.76M$ 3.13M
Total Assets$ 2.67M$ 1.85M$ 6.84M$ 3.96M$ 3.25M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.59M$ -1.78M$ -6.71M$ -3.76M$ -3.13M
Total Liabilities$ 816.00K$ 1.20M$ 3.58M$ 509.00K$ 886.00K
Stockholders' Equity$ 2.80M$ 1.58M$ 3.90M$ 3.45M$ 2.36M
Cash Flow
Free Cash Flow$ -9.03M$ -12.45M$ -7.60M$ -3.75M$ -5.61M
Operating Cash Flow$ -9.03M$ -9.45M$ -7.60M$ -3.75M$ -4.61M
Investing Cash Flow$ 0.00$ -3.00M$ 0.00$ 0.00$ -1.00M
Financing Cash Flow$ 9.84M$ 7.53M$ 10.54M$ 4.38M$ 0.00
Currency in USD

Avenue Therapeutics Earnings and Revenue History

Avenue Therapeutics Debt to Assets

Avenue Therapeutics Cash Flow

Avenue Therapeutics Forecast EPS vs Actual EPS